NCT00000682View on ClinicalTrials.gov

A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1992

Conditions

HIV Infections

Interventions

DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (5)

21287

Johns Hopkins Adult AIDS CRS, Baltimore

33136

Univ. of Miami AIDS CRS, Miami

90033

USC CRS, Los Angeles

92103

Ucsd, Avrc Crs, San Diego

Unknown

Pitt CRS, Pittsburgh

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000682 - A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002 | Biotech Hunter | Biotech Hunter